Newborn affected by noxious substances transmitted via placenta or breast milk
nonteratogenic effects of substances transmitted via placenta
congenital malformations (Q00-Q99)
encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)
newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
P04.0
Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
newborn affected by other maternal medication (P04.1-)
Newborn affected by reactions and intoxications from maternal opiates and tranquilizers administered for procedures during pregnancy or labor and delivery
P04.1
Newborn affected by other maternal medication
dysmorphism due to warfarin (Q86.2)
fetal hydantoin syndrome (Q86.1)
maternal anesthesia and analgesia in pregnancy, labor and delivery (P04.0)
maternal use of drugs of addiction (P04.4-)
P04.11
Newborn affected by maternal antineoplastic chemotherapy
P04.12
Newborn affected by maternal cytotoxic drugs
P04.13
Newborn affected by maternal use of anticonvulsants
P04.14
Newborn affected by maternal use of opiates
P04.15
Newborn affected by maternal use of antidepressants
P04.16
Newborn affected by maternal use of amphetamines
P04.17
Newborn affected by maternal use of sedative-hypnotics
P04.1A
Newborn affected by maternal use of anxiolytics
P04.18
Newborn affected by other maternal medication
P04.19
Newborn affected by maternal use of unspecified medication
P04.2
Newborn affected by maternal use of tobacco
newborn exposure to environmental tobacco smoke (P96.81)
Newborn affected by exposure in utero to tobacco smoke
P04.3
Newborn affected by maternal use of alcohol
fetal alcohol syndrome (Q86.0)
P04.4
Newborn affected by maternal use of drugs of addiction
P04.40
Newborn affected by maternal use of unspecified drugs of addiction
P04.41
Newborn affected by maternal use of cocaine
'Crack baby'
P04.42
Newborn affected by maternal use of hallucinogens
newborn affected by other maternal medication (P04.1-)
P04.49
Newborn affected by maternal use of other drugs of addiction
newborn affected by maternal anesthesia and analgesia (P04.0)
withdrawal symptoms from maternal use of drugs of addiction (P96.1)
P04.5
Newborn affected by maternal use of nutritional chemical substances
P04.6
Newborn affected by maternal exposure to environmental chemical substances
P04.8
Newborn affected by other maternal noxious substances
P04.81
Newborn affected by maternal use of cannabis
P04.89
Newborn affected by other maternal noxious substances
P04.9
Newborn affected by maternal noxious substance, unspecified